Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00376181

Public ClinicalTrials.gov record NCT00376181. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 5:30 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Determine the Efficacy, Safety, and Tolerability of AD-4833-536 in the Treatment of Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of pioglitazone-azilsartan, once daily (QD), in subjects with type 2 diabetes mellitus with poor glycemic control.

Study identification

NCT ID
NCT00376181
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
96 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
May 2007 (Actual)
Completion
May 2007 (Actual)
Last update posted
Jun 22, 2010

2006 – 2007

United States locations

U.S. sites
59
U.S. states
21
U.S. cities
59
Facility City State ZIP Site status
Not listed Huntsville Alabama — —
Not listed Tallassee Alabama — —
Not listed Little Rock Arkansas — —
Not listed Auburn California — —
Not listed Bakersfield California — —
Not listed Buena Park California — —
Not listed Chula Vista California — —
Not listed Huntington Park California — —
Not listed Los Gatos California — —
Not listed Norwalk California — —
Not listed Orangevale California — —
Not listed Sacramento California — —
Not listed Stockton California — —
Not listed Deerfield Beach Florida — —
Not listed Hialeah Florida — —
Not listed Hollywood Florida — —
Not listed Jacksonville Florida — —
Not listed Kissimmee Florida — —
Not listed Marianna Florida — —
Not listed Melbourne Florida — —
Not listed Miami Florida — —
Not listed Pembroke Pines Florida — —
Not listed Winter Haven Florida — —
Not listed Augusta Georgia — —
Not listed Dunwoody Georgia — —
Not listed Chicago Illinois — —
Not listed Bloomington Indiana — —
Not listed Evansville Indiana — —
Not listed Shawnee Mission Kansas — —
Not listed Prince Frederick Maryland — —
Not listed Livonia Michigan — —
Not listed Saint Clair Shores Michigan — —
Not listed Las Vegas Nevada — —
Not listed Trenton New Jersey — —
Not listed Albany New York — —
Not listed Johnson City New York — —
Not listed Staten Island New York — —
Not listed Charlotte North Carolina — —
Not listed Salisbury North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Marion Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Buckingham Pennsylvania — —
Not listed Jeannette Pennsylvania — —
Not listed Mt. Pleasant South Carolina — —
Not listed Simpsonville South Carolina — —
Not listed Bristol Tennessee — —
Not listed New Tazewell Tennessee — —
Not listed Dallas Texas — —
Not listed El Paso Texas — —
Not listed Euless Texas — —
Not listed Fort Worth Texas — —
Not listed Houston Texas — —
Not listed McKinney Texas — —
Not listed Midland Texas — —
Not listed North Richland Hills Texas — —
Not listed San Antonio Texas — —
Not listed Falls Church Virginia — —
Not listed Virginia Beach Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00376181, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2010 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00376181 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →